ASCO Action Center
Immerse yourself in the latest oncological breakthroughs with the ASCO Action Center, which offers an in-depth look at the research and clinical advancements unveiled at the American Society of Clinical Oncology (ASCO) Annual Meeting and even its affiliated conferences like the Genitourinary Cancers (ASCO-GU) and Gastrointestinal Cancers Symposiums. Gain exclusive access to the expert analyses, dynamic discussions, and cutting-edge treatment strategies presented at the conference that are redefining cancer care.
1-15 of 22
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®Advancing HER2-Targeted Therapy in GI Cancers
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®How AI Is Transforming Biomarker Development in GI Oncology
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Project Oncology®Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Project Oncology®Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
- advertisement
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
- advertisement
A Unique Look at the Current and Future Directions of Cancer Vaccines
Project Oncology®A Unique Look at the Current and Future Directions of Cancer Vaccines
The Power of Patient Advocacy in Daily Clinical Practice
Project Oncology®The Power of Patient Advocacy in Daily Clinical Practice
